BMI vs Body Roundness Index (BRI): Which Better Predicts Health Risk?

What Is BMI?

Body Mass Index is calculated as weight in kilograms divided by height in meters squared (kg/m²). It was developed in the 1830s by Adolphe Quetelet, a Belgian astronomer and statistician — not a physician. Quetelet was studying the "average man" for population statistics, never intending his formula to become a clinical diagnostic tool.

Despite its origins, BMI became entrenched in medicine during the 20th century, particularly after the WHO adopted it as the standard obesity classification system in the 1990s. The current WHO categories are:

BMI's fundamental limitations

BMI has two well-documented blind spots that make it problematic for individual health assessment:

1. It cannot distinguish muscle from fat. An NFL running back at 5'11" and 220 lbs has a BMI of 30.7 — "obese" by WHO standards. A sedentary man of the same height and weight gets the same classification. The running back has 12% body fat; the sedentary man has 35%. BMI sees them as identical. Multiple studies have found that BMI misclassifies a substantial portion of adults when compared against body fat measured by DXA, particularly in older adults and those with intermediate BMI values.

2. It tells you nothing about where fat is stored. Two people with identical BMIs can have radically different health profiles depending on whether their fat is visceral (surrounding organs) or subcutaneous (under the skin). Visceral fat is strongly linked to insulin resistance, type 2 diabetes, cardiovascular disease, and certain cancers. Subcutaneous fat, particularly in the lower body, is far less metabolically harmful and may even be protective in some contexts. BMI is completely blind to this distinction.

What Is BRI?

The Body Roundness Index was developed by Diana Thomas and colleagues and published in the journal Obesity in 2013. BRI models the human body cross-section as an ellipse, using waist circumference to estimate the eccentricity (roundness) of that ellipse and height to scale it properly.

The formula is:

BRI values range from approximately 1 (very lean, linear body shape) to 16+ (very round body shape). Higher values indicate a more circular body cross-section, which typically reflects greater central adiposity.

Why BRI captures what BMI misses

The key insight behind BRI is that waist circumference is a proxy for visceral adipose tissue — the metabolically dangerous fat stored around the liver, pancreas, and intestines. This is not subcutaneous fat you can pinch; it is deep abdominal fat that produces inflammatory cytokines and free fatty acids.

Visceral fat is directly implicated in:

• Insulin resistance and type 2 diabetes: Free fatty acids from visceral fat drain into the portal vein and impair hepatic insulin clearance.
• Cardiovascular disease: Visceral adiposity drives chronic low-grade inflammation, endothelial dysfunction, and atherogenic dyslipidemia.
• Certain cancers: The inflammatory environment created by visceral fat is associated with increased risk of colorectal, pancreatic, and postmenopausal breast cancers.
• All-cause mortality: Multiple large cohort studies show that waist-based metrics outperform BMI in predicting who dies earlier.

By modeling body shape rather than just body size, BRI captures the distribution of tissue that matters most for metabolic health — something BMI was never designed to do.

Head-to-Head Comparison

What the Research Says

Zhang et al. (2024) — A landmark mortality study

A large and influential study in the BMI-vs-BRI debate was published in JAMA Network Open in June 2024. Zhang and colleagues analyzed data from 32,995 US adults in the NHANES 1999-2018 cohort, with mortality follow-up through December 2019 (median 10.0 years, maximum ~21 years).

Key findings:

• BRI showed a U-shaped mortality curve — both very low BRI and very high BRI were associated with increased risk.
• A BRI above 6.9 was associated with a hazard ratio of 1.49 for all-cause mortality compared to the reference group.
• BRI outperformed BMI in predicting cardiovascular mortality specifically — the domain where fat distribution matters most.
• The association was robust after adjusting for age, sex, race/ethnicity, education, smoking, alcohol, and comorbidities.

This study confirmed what waist-based metric proponents had argued for decades: where fat sits matters more than how much you weigh.

Thomas et al. (2013) — The original BRI development

The BRI was first described in a 2013 paper in Obesity by Diana Thomas and colleagues. The researchers developed a geometric model that treats the body as an ellipse and validated it against DXA-measured body fat percentage. They found that BRI correlated more strongly with total body fat and visceral adipose tissue than BMI did.

This paper established the mathematical foundation and showed that a simple waist-and-height measurement could approximate the body shape information that previously required expensive imaging.

Krakauer & Krakauer (2012) — BRI predicts mortality

In a 2012 PLoS ONE paper, Nir Krakauer and Jesse Krakauer analyzed NHANES 1988-1994 data with mortality follow-up and found that a new body shape index (ABSI, related to BRI) predicted mortality hazard independently of BMI. This work laid the groundwork for the shift from weight-based to shape-based health metrics.

2022 meta-analysis — BRI strongest for metabolic syndrome

A 2022 meta-analysis published in Frontiers in Endocrinology compared 7 body shape indices (BMI, BRI, ABSI, WHtR, WHR, WC, and CI) for their association with metabolic syndrome. BRI had the strongest overall association, outperforming all other indices including BMI and waist circumference alone.

When Each Metric Is More Useful

BMI is better for:

• Population-level surveillance: BMI is quick, requires no undressing, and works at scale. Public health trends over decades rely on consistent BMI data.
• Quick initial screening: In a busy primary care setting, height and weight are already measured. BMI flags who needs further investigation.
• Research continuity: Decades of longitudinal studies use BMI. Switching metrics disrupts comparisons with historical data.
• Tracking weight changes over time: For a given individual, BMI trends reflect weight trends — useful for monitoring intentional weight loss or gain.

BRI is better for:

• Individual health risk assessment: BRI captures the fat distribution that drives most metabolic disease. For one person, it is the superior risk indicator.
• People with high muscle mass: Athletes, bodybuilders, and physically active individuals are frequently misclassified by BMI. BRI is less susceptible to this error.
• Distinguishing metabolically healthy vs. unhealthy obesity: Some people with high BMI are metabolically healthy ("MHO"); others with normal BMI are metabolically obese ("MONW" or "TOFI" — thin outside, fat inside). BRI helps identify the latter group.
• Older adults: The "obesity paradox" — where higher BMI appears protective in older populations — may be partly an artifact of BMI's inability to distinguish muscle from fat. Older adults lose muscle (sarcopenia) while gaining visceral fat. BMI can remain stable or even drop as this happens, masking metabolic deterioration. Waist-based metrics like BRI capture the dangerous fat gain that BMI misses.

What Is a Healthy BRI?

Unlike BMI, BRI does not yet have universally accepted clinical cutoffs. However, based on the Thomas et al. (2013) original paper and subsequent validation studies, the following ranges provide a reasonable framework:

Studies suggest keeping BRI below 4-5 for optimal health outcomes. The Zhang et al. (2024) study found that a BRI of approximately 4.5-5.5 represented the lowest mortality risk zone, with risk increasing sharply above 6.9.

How to Calculate Both

Calculating BMI

1. Weigh yourself in kilograms (divide pounds by 2.205).
2. Measure your height in meters (divide inches by 39.37, or feet × 0.3048).
3. Divide: BMI = weight ÷ (height × height).
4. Example: 80 kg at 1.75 m → 80 ÷ (1.75 × 1.75) = 26.1 (overweight).

Calculating BRI

1. Measure your waist circumference at navel level (not where your pants sit). Exhale normally — do not suck in your stomach. Use centimeters for precision.
2. Measure your height in centimeters.
3. Calculate waist eccentricity: ε = √(1 − ((WC / (2π))² / (0.5 × height)²)).
4. Convert to BRI: BRI = 364.2 − 365.5 × ε.
5. Example: 90 cm waist at 175 cm height → ε = √(1 − ((90/6.283)² / (87.5)²)) = √(1 − (205.3 / 7656.3)) = √(1 − 0.0268) = 0.9864 → BRI = 364.2 − 365.5 × 0.9864 = 364.2 − 360.5 = 3.7 (average).

Our BRI calculator and BMI percentile calculator do all of this math instantly, plus compare your results to US adults using NHANES data.

The Bigger Picture: Why Body Shape Matters More Than Weight

The shift from BMI to BRI reflects a deeper evolution in obesity science. For most of the 20th century, excess weight was seen as a uniform condition — you either had too much or you did not. Research over the past 30 years has revealed a far more nuanced picture:

• Not all fat is equal. Subcutaneous fat in the hips and thighs may be metabolically neutral or even protective. Visceral fat in the abdomen is strongly pathogenic.
• Not all lean people are healthy. "TOFI" (thin outside, fat inside) individuals — normal BMI but high visceral fat — have the same metabolic risk as overtly obese individuals.
• Not all obese people are unhealthy. "Metabolically healthy obesity" (MHO) exists, typically in people who carry excess subcutaneous but not visceral fat. BRI helps identify MHO better than BMI.

BRI is part of a family of body shape indices — along with ABSI (A Body Shape Index), WHtR (Waist-to-Height Ratio), and WHR (Waist-to-Hip Ratio) — that attempt to capture this complexity. Among them, BRI has the strongest evidence base for mortality prediction as of 2024.

The Bottom Line

BMI served public health well for a century, but it is a blunt instrument. If you want to know whether your body composition is putting you at risk, measure your waist. Better yet, calculate your BRI — it is the same two measurements with a smarter formula behind it.

BMI will not disappear overnight. It is embedded in insurance underwriting, drug dosing, surgical guidelines, and millions of electronic health records. But as the evidence accumulates — the 2024 JAMA study, the 2022 meta-analysis, and decades of waist circumference research — the case for adding shape-based metrics to routine clinical assessment grows stronger every year.

For now, the practical takeaway is: know both numbers, but pay more attention to your waist.